Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31597 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.30123 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.30148 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.25643 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.24289 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.34271 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.32673 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.27877 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.27519 | 12 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.29205 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.28695 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.34875 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.29187 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.29223 | 12 |